Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study
暂无分享,去创建一个
P. Ghaneh | G. Poston | N. Kitteringham | B. K. Park | C. Rowe | H. Malik | D. Carr | R. Jenkins | S. Fenwick | E. O’Grady | Robert P. Jones | R. Jenkins | R. Jones | J. Hamlett | M. Terlizzo | P. Sutton | R. M. Greensmith | A. Santoyo-Castelazo | B. Park | R. Jenkins